The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE/TRIO-012 trial.
 
Sambasivarao Damaraju
Research Funding - Lilly/ImClone
 
Vera Gorbunova
No Relationships to Disclose
 
Karen A. Gelmon
No Relationships to Disclose
 
Jose Angel Garcia Saenz
No Relationships to Disclose
 
Serafin Morales
No Relationships to Disclose
 
Dany Youssef Abigerges
No Relationships to Disclose
 
Jean-Luc Canon
No Relationships to Disclose
 
Igor Lifirenko
No Relationships to Disclose
 
Graham Lawrence Cohen
No Relationships to Disclose
 
Guy Heinrich Maria Jerusalem
Honoraria - Celgene; Novartis; Roche
Consulting or Advisory Role - Celgene; Novartis
Research Funding - MSD; Novartis; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Francois Thireau
No Relationships to Disclose
 
Rodrigo Fresco
No Relationships to Disclose
 
Vincent Houé
No Relationships to Disclose
 
Michael F. Press
Honoraria - Amgen; Biocartis; Cepheid; Dako; GlaxoSmithKline; Halozyme; NanoString Technologies; OncoMed; Puma Biotechnology
Consulting or Advisory Role - Amgen; Biocartis; Cepheid; Dako; GlaxoSmithKline; Halozyme; NanoString Technologies; OncoMed; Puma Biotechnology
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Dako; Dendreon
 
Ashok Narasimhan
No Relationships to Disclose
 
John Robert Mackey
Consulting or Advisory Role - ImClone Systems; Roche/Genentech
Research Funding - ImClone Systems; Roche/Genentech